VIET NGUYEN: Open Payments
NPI 1245406636 · FALLS CHURCH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,041 in 24 payments from 9 companies in 2025. Trend: 2023 $849 · 2024 $776 · 2025 $1,041
Food & beverage: $1,041
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $406 |
| Novo Nordisk Inc | 4 | $258 |
| Kowa Pharmaceuticals America, Inc. | 3 | $168 |
| Lilly USA, LLC | 2 | $57 |
| Amgen Inc. | 2 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $31 |
| Exact Sciences Corporation | 1 | $24 |
| Medtronic, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: AIRSUPRA, ZORYVE, Ozempic, Wegovy, FARXIGA, MOUNJARO, OTEZLA, CAPLYTA.
Industry payments across VA — which companies pay providers there.
